Cilag is an internationally operating company, part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Founded in 1936, Cilag AG has been committed to delivering high-quality active pharmaceutical ingredients and products globally. Their slogan "Elevating global pharmaceutical quality through meticulous standards and a dedicated, highly skilled team of over 1000 professionals" reflects their dedication to maintaining global Quality, Health, Safety, and Environmental standards. With over 1,000 well-trained, conscientious, and highly motivated employees, they are regarded as their most valuable asset.
Cilag operates in the Health Care industry and maintains a strong focus on quality and safety. While specific details about the company's headquarters and recent investments are not available, the company's long-standing presence in the pharmaceutical industry and its association with Johnson & Johnson positions it as a stable and reliable investment opportunity for venture capitalists looking to enter the health care sector. With a focus on global reach and meticulous attention to quality, Cilag presents a compelling proposition for investors seeking to contribute to the advancement of pharmaceutical standards and products on a global scale.
